MARX Biotech Co (ROCO:7731) Operating Margin %: -30.36% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7731 MARX Biotech Co Ltd ROCO:7731
10 GF Score
Price NT$4.87
! 4 Warning Signs
View Full Analysis

What is MARX Biotech Co Operating Margin %?

MARX Biotech Co ROCO:7731 -3.18% 10 Operating Margin % is -30.36% as of Dec. 2025. GuruFocus rates ROCO:7731 with a GF Score™ of 10/100. The stock has 4 warning signs investors should review. Among 665 Healthcare Providers & Services companies, MARX Biotech Co ranks worse than 83.31% on this metric.

Operating Margin % is calculated as Operating Income divided by its Revenue. MARX Biotech Co's Operating Income for the six months ended in Dec. 2025 was NT$-99.2 Mil. MARX Biotech Co's Revenue for the six months ended in Dec. 2025 was NT$326.9 Mil. Therefore, MARX Biotech Co's Operating Margin % for the quarter that ended in Dec. 2025 was -30.36%.

The historical rank and industry rank for MARX Biotech Co's Operating Margin % or its related term are showing as below:

ROCO:7731' s Operating Margin % Range Over the Past 10 Years
Min: -21.93   Med: -4.94   Max: 17.3
Current: -21.93


ROCO:7731's Operating Margin % is ranked worse than
83.31% of 665 companies
in the Healthcare Providers & Services industry
Industry Median: 4.87 vs ROCO:7731: -21.93

MARX Biotech Co's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

MARX Biotech Co's Operating Income for the six months ended in Dec. 2025 was NT$-99.2 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2025 was NT$-139.5 Mil.

Warning Sign:

MARX Biotech Co Ltd has never been profitable in the past 3 years. It lost money every year.


MARX Biotech Co  (ROCO:7731) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


MARX Biotech Co Operating Margin % Related Terms


MARX Biotech Co Operating Margin % Historical Data

* Premium members only.

The historical data trend for MARX Biotech Co's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MARX Biotech Co Operating Margin % Chart

MARX Biotech Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Operating Margin %
Get a 7-Day Free Trial 17.30 1.71 -4.94 -12.52 -21.93

MARX Biotech Co Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.53 -19.57 -8.78 -13.02 -30.36

MARX Biotech Co Operating Margin % Competitor Comparison

For the Pharmaceutical Retailers subindustry, MARX Biotech Co's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MARX Biotech Co Operating Margin % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, MARX Biotech Co's Operating Margin % distribution charts can be found below:

* The bar in red indicates where MARX Biotech Co's Operating Margin % falls into.


ROCO:7731
10GF Score
MARX Biotech Co Ltd ROCO:7731
Operating Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MARX Biotech Co Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

MARX Biotech Co's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as

Operating Margin %=Operating Income (A: Dec. 2025 ) / Revenue (A: Dec. 2025 )
=-139.459 / 635.852
=-21.93 %

MARX Biotech Co's Operating Margin % for the quarter that ended in Dec. 2025 is calculated as

Operating Margin %=Operating Income (Q: Dec. 2025 ) / Revenue (Q: Dec. 2025 )
=-99.245 / 326.931
=-30.36 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Margin % →
What does a Operating Margin % of -30.36% mean?
MARX Biotech Co (ROCO:7731) has a Operating Margin % of -30.36% as of Dec. 2025. Operating margin is the ratio of total operating income to net sales. View historical data on MARX Biotech Co and its competitors. According to the industry distribution chart, MARX Biotech Co ranks #554 out of 665 companies in the Healthcare Providers & Services industry, placing it in the top 83.3%.
Is MARX Biotech Co's Operating Margin % too high?
MARX Biotech Co's current Operating Margin % is -30.36%. Based on the distribution chart, MARX Biotech Co ranks #554 out of 665 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, MARX Biotech Co has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does MARX Biotech Co's Operating Margin % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, MARX Biotech Co ranks #554 out of 665 companies for Operating Margin %. This places MARX Biotech Co in the lower half of its industry. The industry median Operating Margin % is 4.87. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Healthcare Providers & Services company?
The median Operating Margin % among Healthcare Providers & Services companies is 4.87, based on 665 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on MARX Biotech Co and its competitors. For the Healthcare Providers & Services industry, the median Operating Margin % is 4.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MARX Biotech Co's current Operating Margin % is -30.36%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MARX Biotech Co stock overvalued right now?
MARX Biotech Co (ROCO:7731) has a current Operating Margin % of -30.36%. The current Operating Margin % is -30.36%. MARX Biotech Co's overall GF Score™ is 10/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For MARX Biotech Co (ROCO:7731), the current Operating Margin % is -30.36% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MARX Biotech Co Business Description

Address 5th Floor, No. 655, Bannan Road, Zhonghe district, New Taipei, TWN
MARX Biotech Co Ltd is a retail company which has developed an O2O and OMO full-channel layout in the online Internet platform and cosmeceutical retail market, and has successfully established itself in the market and Build trust and operational growth on the channel side. It has has established more than three thousand large and small cosmeceutical pharmacies in Taiwan, including: Dashu Pharmacy, Dingding Pharmacy, Cosmed, Watsons, Spring Pharmacy, New Gaoqiao Pharmacy, Anlier Pharmacies, etc.
10GF Score

Get the complete analysis for ROCO:7731

Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$4.87
Price